NEUROLOGICAL AUTOIMMUNE DISEASES
Clinical trials for NEUROLOGICAL AUTOIMMUNE DISEASES explained in plain language.
Never miss a new study
Get alerted when new NEUROLOGICAL AUTOIMMUNE DISEASES trials appear
Sign up with your email to follow new studies for NEUROLOGICAL AUTOIMMUNE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets Hard-to-Treat nerve diseases
Disease control Recruiting nowThis early-stage study tests a new cell therapy called CNCT19 in 18 adults with relapsed or treatment-resistant autoimmune neurological diseases like neuromyelitis optica. The goal is to see if it is safe and can help control the disease by targeting certain immune cells. Partici…
Matched conditions: NEUROLOGICAL AUTOIMMUNE DISEASES
Phase: EARLY_PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Experimental cell therapy takes on stubborn brain autoimmune disorders
Disease control Recruiting nowThis early-stage trial is testing a new cell therapy called GT719 in 30 adults with recurrent or hard-to-treat neurological autoimmune diseases. The goal is to see if it is safe and how long the cells last in the body. Researchers will also look for early signs that it might help…
Matched conditions: NEUROLOGICAL AUTOIMMUNE DISEASES
Phase: PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 26, 2026 17:13 UTC
-
Blood filtering treatment tested for nerve disorders in egyptian patients
Knowledge-focused Recruiting nowThis study looks at how well therapeutic plasma exchange (a blood-filtering procedure) works for people with autoimmune neurological diseases. Researchers at Al-Azhar University Hospitals will follow 60 Egyptian patients to see if their symptoms and daily function improve. The go…
Matched conditions: NEUROLOGICAL AUTOIMMUNE DISEASES
Sponsor: Al-Azhar University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC